As of Oct 21
| +0.05 / +1.06%|
The 1 analysts offering 12-month price forecasts for Derma Sciences Inc have a median target of 8.50, with a high estimate of 8.50 and a low estimate of 8.50. The median estimate represents a +78.95% increase from the last price of 4.75.
The current consensus among 1 polled investment analysts is to Buy stock in Derma Sciences Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.